Table 1.
Group 1—Pulmonary Arterial Hypertension |
---|
1.1 Idiopathic PAH |
1.2 Heritable PAH |
1.3 Drug- and toxin-induced PAH |
1.4 PAH associated with: |
1.4.1 Connective tissue disease |
1.4.2 HIV infection |
1.4.3 Portal hypertension |
1.4.4 Congenital heart disease |
1.4.5 Schistosomiasis |
1.5 PAH long-term responders to calcium channel blockers |
1.6 PAH with overt features of venous/capillaries (PVOD/PCH) involvement |
1.7 Persistent PH of the newborn syndrome |
HIV, human immunodeficiency viruses, PAH, pulmonary arterial hypertension; PCH, pulmonary capillary hemangiomatosis; PVOD, pulmonary veno-occlusive disease.